Attachment A.pdf

p

MARION VA MEDICAL CENTER

ASBESTOS & LEAD SURVEY REPORT

VOLUME II - BUILDING 138

Project No. R2019047.000.003 September 25, 2020

Prepared for:

VA Northern Indiana Health Care System Marion Campus 1700 East 38th Street Marion, Indiana 46953

Mabbett & Associates, Inc.

105 Central Street, Suite 4100 Stoneham, MA 02180 T. 781-275-6050 Massachusetts | Virginia | Rhode Island | New York www.mabbett.com

© 2020, Mabbett & Associates, Inc.

RIM VOLUME II, BUILDING 138 - ASBESTOS & LEAD SURVEY REPORT

Marion VA Medical Center | Marion, IN

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. i September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

ACKNOWLEDGEMENT

This Asbestos Containing Materials (ACM) and Lead Containing Paint (LCP) Survey Report was prepared for the Veterans Affairs (VA) Northern Indiana Health Care System, Marion VA Medical Center (VAMC) in accordance with established scope of work as defined in Contract Number GS-10F-0120T. The information presented herein is based on the facts and information conveyed to or received by the Mabbett & Associates, Inc. (Mabbett®) Team during the preparation of this report. If any of the information provided to Mabbett that was used in preparing this report is incorrect, incomplete, or subject to change, Mabbett would wish to alter its opinion(s) accordingly. In addition, the professional opinions and information contained in this report are based solely on the requirements of the applicable regulations and technical data as known to Mabbett as of the date of this report and considered applicable to this report.

The individual building reports within Volume II, which contain building specific asbestos and lead findings, are part of the Marion VA Medical Center Asbestos and Lead Based Paint Survey Report consisting of the following Volumes:

Volume I - General

Chapter 1 – Introduction and Executive Summary Chapter 2 – Asbestos Operations & Maintenance (O&M) Management Plan Chapter 3 – Lead Containing Paint O&M Management Plan

Volume II – Individual Building Reports

Individual Building Reports Chapters including:

Cover page with building number Building narrative summary Relevant asbestos findings for the building Relevant lead-based paint screening findings for the building Floor plans Relevant photos Appendices and supporting data

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. ii September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

This report was prepared by Kevin M. Donovan, Sr. Environmental, Health and Safety Specialist - Indiana Asbestos Inspector #19A012050.

This report has been reviewed and approved by:

Mabbett & Associates, Inc.

Michael F. Delaney Director, Building Sciences Group Indiana Asbestos Inspector #A19A011952 Indiana Asbestos Management Planner #19A011954

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. iii September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

TABLE OF CONTENTS

SECTION PAGE

1.0 INTRODUCTION & EXECUTIVE SUMMARY

2.0 BUILDING DESCRIPTION

3.0 ASBESTOS SURVEY

3.1 Sampling Methodology

3.2 Analytical Methodology

3.3 Summary of Asbestos Containing Materials (ACM) Findings

3.3.1 Data Tables, Laboratory Results, and Field Notes

3.3.2 Photographs

3.3.3 CADD Drawings

4.0 LEAD SCREENING SURVEY

4.1 Screening Survey Methodology

4.2 Summary of Lead Screening Survey Findings

4.2.1 Data Tables

4.2.2 Photographs

4.2.3 CADD Drawings

5.0 LIMITATIONS

6.0 CLOSING REMARKS

6.1 Asbestos

6.2 Lead-Based Paint

TABLES

Table 1 – Summary of Identified ACM (in text) Table 2 – Summary of Positive XRF Results (in text)

FIGURES

Figure 1 – Asbestos Survey Summary Plan – Building 138 – Basement Figure 2 – Asbestos Survey Summary Plan – Building 138 – First Floor Figure 3 – Asbestos Survey Summary Plan – Building 138 – Second Floor Figure 4 – Asbestos Survey Summary Plan – Building 138 – Third Floor Figure 5 – Asbestos Survey Summary Plan – Building 138 – Fourth and Fifth Floors Figure 6 – Lead-based Paint Survey Summary Plan – Building 138 – Basement Figure 7 – Lead-based Paint Survey Summary Plan – Building 138 – First Floor Figure 8 – Lead-based Paint Survey Summary Plan – Building 138 – Second Floor Figure 9 – Lead-based Paint Survey Summary Plan – Building 138 – Third Floor Figure 10 – Lead-based Paint Survey Summary Plan – Building 138 – Fourth and Fifth Floors

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. iv September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

APPENDICES

Appendix A – Accreditation Certificates Appendix B – Table 3, Summary of ACM Sampling Results Appendix C – Laboratory Analytical Results and Chain of Custody Appendix D – Representative Photographs of ACM Appendix E – Table 4, Summary of XRF Measurements Appendix F – Representative Photographs of Identified Lead-Based Paint

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. 1 September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

1.0 INTRODUCTION & EXECUTIVE SUMMARY

Mabbett and Associates, Inc. (Mabbett®), with ECS Midwest, LLC as a sub-contractor, performed surveys for suspect asbestos containing building materials (ACM) and screenings of suspect lead-based paint on building surfaces utilizing an X-Ray Fluorescence (XRF) analyzer. Surveys were performed of Building 138 at the Marion VA Medical Center (Marion VAMC) located at 1700 East 38th Street in Marion, Indiana, under Contract GS-10F-0120T. Site survey work was performed on December 10, 2019 and on February 21, 2020 by appropriately credentialed personnel as required. Collected suspect ACM samples were submitted to an analytical laboratory certified as an environmental testing laboratory pursuant to the provisions of the Health and Safety Code for bulk asbestos analysis by polarized light microscopy (PLM) using positive stop methodology. The survey effort involved the collection or screening of the following samples, resulting in the following conclusions:

Eighty-six (86) bulk samples for suspect ACM were collected in this building.

Based on laboratory analysis of suspect ACM, five (5) samples contained asbestos greater than 1%.

One (1) additional material was previously identified as ACM or Presumed ACM (PACM).

One hundred and seventy-one (171) lead screening measurements were taken in this building.

Twenty-five (25) lead screening measurements were greater than 1.0 mg/cm2.

This building report consists of a summary of findings, floor plans that indicate positive sample locations, detailed analytical findings for the specific surveyed building materials, relevant photos, and laboratory analytical reports.

2.0 BUILDING DESCRIPTION

According to information provided by The Department of Veterans Affairs VA Northern Indiana Health Care System (VANIHCS) and observations made by the Mabbett team at the time of the survey, Building 138 is a five-story steel and masonry structure on a concrete basement foundation with a flat roof, and encompasses approximately 116,069 square feet. The building is used as a clinical / medical building and was reportedly built in 1958.

3.0 ASBESTOS SURVEY

3.1 Sampling Methodology

The Mabbett team performed a physical U.S. Environmental Protection Agency (EPA) Asbestos Hazard and Emergency Response Act (AHERA) type inspection and sampling of suspect materials as required by EPA AHERA regulations (i.e. 40 CFR 763), Occupational Safety and Health Administration (OSHA) Asbestos Standards (i.e. 29 CFR

1910.1001 & 29 CFR 1926.1101) and the VHA Asbestos Management Program (VHA Directive 7714).

The VANIHCS provided Mabbett with historical asbestos inspection reports for asbestos surveys that were previously conducted at the Marion VAMC. The surveys were conducted by L.B. Kimball in May 2011 and by USFIN Development, LLC in August 2016. These reports were reviewed by the Mabbett team prior to performing inspection activities. In some instances, ACM identified by the previous surveys was confirmed by Mabbett, reassessed, and included in this Asbestos & Lead Survey Report.

A visual screening inspection was conducted to identify locations of suspect ACM throughout identified areas of the building by EPA Asbestos Hazard Emergency Response Act (AHERA) accredited and Indiana certified asbestos inspectors. Copies of inspector accreditation certificates are provided in Appendix A. Only areas that were accessible during the field work phase were inspected. Every effort was made during the initial field survey work to access areas as necessary to complete the survey.

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. 2 September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

General areas that were inaccessible or where the survey was limited to visual observation only are identified below:

Below newer finishes, flooring, caulking, etc.

Within fire doors Within walls and enclosed pipe/duct chases Inside mechanical equipment/ductwork Above fixed drywall or plaster ceilings without access panel

Due to these access restrictions, a comprehensive pre-demolition ACM survey, in accordance with Asbestos National Emission Standards for Hazardous Air Pollutants (NESHAP) regulations, should be performed prior to any proposed renovations or maintenance involving inaccessible areas. Roofing materials were not sampled in order to maintain applicable warranties.

Bulk samples were collected of suspect ACM in accordance with EPA AHERA regulations. Bulk suspect ACM sampling was conducted according to the following sampling plan:

a) Surfacing material:

a. At least three bulk samples were collected from each homogeneous area that is 1,000 ft2 or less.

b. At least five bulk samples were collected from each homogeneous area that is greater than 1,000 ft2 but less than or equal to 5,000 ft2.

c. At least seven bulk samples were collected from each homogeneous area that is greater than

5,000 ft2.

b) Thermal system insulation:

a. At least three bulk samples were collected from each homogeneous area of thermal system insulation.

b. At least one bulk sample was collected from each homogeneous area of patched thermal system insulation.

c. Sufficient samples were collected from elbows and fittings to determine if they contain ACM.

d. Bulk samples were not collected from any homogeneous area where the state licensed asbestos inspector determined that the thermal system insulation is fiberglass, foam glass, rubber, or other non-ACM.

c) Miscellaneous material:

a. At least one bulk sample was collected from each homogeneous area.

b. At least two bulk samples were collected from each homogeneous area that is greater than 100 ft2.

3.2 Analytical Methodology

The collected bulk samples were submitted under chain of custody procedures to Scientific Analytical Institute (SAI) of Greensboro, North Carolina. SAI is accredited by the American Industrial Hygiene Association (AIHA) and participates in the National Voluntary Laboratory Accreditation Program (NVLAP Lab Code 200664-0). Bulk samples were analyzed by PLM using EPA Method 600/R-93/116.

Bulk sample results are summarized in Table 3 – Summary of ACM Sampling Results and included as Appendix B. The EPA and OSHA defines any material that contains greater than one percent (>1%) asbestos as being an ACM. As

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. 3 September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc such, the analytical laboratory identified bulk samples as asbestos-containing materials that met the regulatory criteria of greater than or equal to one percent ( 1%) asbestos. Laboratory reports and the chain of custodies are provided in Appendix C of this report.

3.3 Summary of Asbestos Containing Materials (ACM) Findings

3.3.1 Data Tables, Laboratory Results, and Field Notes

Mabbett sampled thirty-eight (38) types of homogenous materials and collected eighty-six (86) representative bulk ACM samples. Eighty-four (84) samples were analyzed by PLM and two (2) samples were positive stops and not analyzed. The current and historical laboratory analytical data indicated that six (6) homogenous materials had greater than 1% asbestos and were ACM or PACM. Estimated quantities of materials identified as ACM or PACM are presented in Table 1 below:

TABLE 1

VA Northern Indiana Health Care System

Marion VAMC, Building 138 Summary of ACM

Sample / Homogeneous

Area No.

Location Description of

Material

Percent and Type of

Asbestos

Estimated Quantity Material

Type

Condition/Control Method/Remedial

Action Amount Units 138-15B Room 372C Black Sink Coat 3% Chrysotile 1 EA Misc. Good/O&M/None

138-19A Throughout Heater Panel (Cement Board)

20% Chrysotile 200 EA Misc. Good/O&M/None

138-28B Rooms 16, 317A,B,C,D, C301

12"x12" Beige Floor Tile Mastic 3% Chrysotile 1,200 SF Misc. Good/O&M/None

138-35A Exterior Window Frame Glaze 3% Chrysotile 375 EA Misc. Good/O&M/None

138-37A - A Exterior Gray Window Frame Caulk 2% Chrysotile 375 EA Misc. Good/O&M/None

Concealed Inside Pipe

Chases, Walls, and Ceilings

Pipe Insulation PACM ND LF TSI Not Accessed

Notes:

EA = Each PACM = Presumed ACM LF = Linear Feet Misc. = Miscellaneous Material SF = Square Feet TSI = Thermal System Insulation ND = Not Determined * = Material Identified as ACM by Previous Testing

3.3.2 Photographs

Representative photographs of ACM Homogeneous Areas are provided in Appendix D of this report.

3.3.3 CADD Drawings

The location of each collected bulk sample and its abridged sample ID is shown on the CADD drawings in the Figures Section of this report. Each identified ACM sample location is colored red and marked with an asterisk (*), while positive stops are marked with two asterisks (**). Collected bulk samples that did not contain asbestos are identified

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. 4 September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc solely by the sample ID. Building areas containing ACM are identified with hatching or symbols to show the approximate location of the identified ACM.

4.0 LEAD SCREENING SURVEY

4.1 Screening Survey Methodology

Mabbett completed a limited lead-based paint screening survey of Building 138 components which included painted building surfaces. The lead-based paint screening survey was performed by a certified lead inspector. The screening survey measured lead concentrations in accessible building surfaces by using a Heuresis Corp. Pb200i Handheld XRF Paint Analyzer (serial number 1752). The XRF instrument was calibrated at the frequency specified by the manufacturer. Every effort was made during the initial field survey work to access areas as necessary to complete the survey.

4.2 Summary of Lead Screening Survey Findings

4.2.1 Data Tables

A concentration of lead greater than or equal to 1.0 mg/cm2 exceeds HUD residential standards and is an indicator of risk. OSHA does not specify a safe concentration of lead. Painted interior building components screened using an XRF found to contain lead at concentrations greater than 1.0 mg/cm2 have been included in Table 2 below:

TABLE 2

VA Northern Indiana Health Care System

Marion VAMC, Building 138 Summary of Positive XRF Results

Reading No Floor/Room Location Component Substrate Condition Color Result

(mg/cm2)

333 0 004 Door metal Intact brown 2.0 334 0 004 Door Frame metal Intact brown 2.0 337 0 007 Door frame metal Intact brown 1.4 341 0 003 Door frame metal Intact brown 2.7 345 0 003E wall ceramic Intact yellow 1.1 362 0 outside 001 beam metal Damaged green 1.0 382 0 018 door frame metal Intact brown 2.0 387 0 005 wall ceramic Intact yellow 2.2 388 0 005 wall ceramic Intact yellow 1.7 435 2 203 door frame metal Intact tan 15.8 436 2 202 Door Frame metal Intact tan 11.2 452 2 stairwell 3 railing metal Intact gray 2.0 456 2 Stairwell 1 railing metal Intact brown 1.8 460 2 Stairwell 2 railing metal Intact white 1.5 461 2 Stairwell 2 window frame wood Intact white 4.9 463 3 Stairwell 2 Door frame metal Intact black 2.5

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. 5 September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

TABLE 2

VA Northern Indiana Health Care System

Marion VAMC, Building 138 Summary of Positive XRF Results

Reading No Floor/Room Location Component Substrate Condition Color Result

(mg/cm2)

466 3 321 door frame metal Intact Gray 1.7 472 3 306 window frame plaster Intact white 2.3 473 3 306 window frame plaster Intact white 2.3 474 3 328 door frame metal Intact brown 1.8 477 3 302A Door Frame metal Intact brown 1.6 478 3 302A window frame plaster Intact white 1.3 481 3 333 Door Frame metal Intact brown 1.5 486 3 337A window frame plaster Intact white 1.8 499 3 Penthouse railing metal Damaged green 4.7

A complete summary of XRF measurements collected during the screening survey of interior and exterior building components are included in Table 4 – Summary of XRF Measurements and included as Appendix E. Table 4 includes a description of each screened surface and resulting XRF-measured lead-based paint concentration.

4.2.2 Photographs

Representative photographs of components identified with > 1.0 mg/cm2 lead content are provided in Appendix F of this report.

4.2.3 CADD Drawings

Based on the results of the lead-based paint screening survey, Mabbett created figures representing all materials with lead content > 1.0 mg/cm2. The information presented on the CADD drawings is for use by the VAMC for exposure assessments and preliminary renovation planning. Based on the results of the survey, these components identified in the CADD table and on the plan should be assumed to be lead-based paint containing unless otherwise determined.

5.0 LIMITATIONS

This inspection report is the result of a diligent search of identified areas of Building 138 for ACM and LBP. Only accessible and authorized areas/materials were included in this survey. Although a comprehensive inspection was performed, Mabbett does not claim to have identified all ACM and LBP that could be present in the facility (for example, materials potentially located within aforementioned inaccessible areas in Section 3.1). Mabbett’s survey was performed with limitations inherent to visual inspections. Mabbett has conducted this assessment with reasonable care and has performed this project within generally accepted industry standards. There can be no assurances, and Mabbett makes no assurances, that the information, research, and technology used to prepare this report may not change in the future, thus affecting the results reported herein.

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. 6 September 25, 2020 Project No. R2019047.000.003 S:\ADMINA\2019047 Northern Indiana VAMC\000\003\Bldg 138\VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final.doc

6.0 CLOSING REMARKS

6.1 Asbestos

Prior to initiating plans for maintenance activities, the Marion VAMC should review the asbestos survey results to determine whether any of the materials identified as ACM will be disturbed by proposed work activities. This report may not be used as a renovation/demolition NESHAP type inspection report. Prior to any renovation/demolition activities, a full destructive asbestos inspection of the work area including any previously inaccessible or unsampled materials that might be impacted must be conducted.

The purpose of this ACM survey was to create an Operations and Maintenance (O&M) Plan and to identify ACM in Building 138 within the limitations of the survey for worker protection purposes only and not for future renovation or demolition purposes. In regard to asbestos, any suspect material encountered during maintenance activities that is not identified in this report as being non-ACM should be assumed to be ACM unless laboratory analytical data for bulk samples prove otherwise. Suspect ACM that may be present within the walls, above inaccessible hard ceilings, or in other inaccessible locations, and that accordingly was not inspected, should be assumed to contain asbestos if discovered until otherwise verified, as previously described. If ACM must be disturbed, the ACM must be removed by a licensed asbestos abatement contractor and be performed in accordance with applicable regulations. If proposed work activities will not disturb intact ACM, continuous monitoring of ACM should be conducted throughout work activities to ensure the ACM remains in an intact condition. Additionally, prior to commencing work activities, personnel involved with the work activities should be made aware of the location of ACM within the building in which they will be working. Additional information regarding asbestos management and the Operations & Maintenance (O&M) program is outlined in the VAMC campus-wide Asbestos O&M Management Plan available in Volume I of the Marion VAMC Survey Report.

6.2 Lead-Based Paint

The purpose of the lead-based paint screening survey was to identify LBP components. For the purpose of this lead-based paint screening survey, representative interior and exterior building components i.e. painted building components were tested. The regulations addressing lead in non-residential buildings are focused on protecting workers involved with lead-based paint disturbing activities and related waste disposal activities.

Worker protection is regulated by OSHA regulations as well as applicable state regulations. These regulations involve air monitoring of workers to determine exposure levels when disturbing lead-based paint materials with measurable lead. A lead-based paint investigation cannot determine a safe level of lead but is intended to provide guidance as to the locations of where lead containing paint is present. VA employees and contractors may use this information to better determine exposures of workers to airborne lead by understanding the different concentrations of lead paint on representative components and surfaces. Worker exposure controls can then be implemented, and air monitoring can then be performed during activities that disturb lead-based paint on representative surfaces.

A concentration of lead greater than or equal to 1.0 mg/cm2 exceeds HUD residential standards and is an indicator of risk. OSHA does not specify a safe concentration of lead. Prior to demolition of lead containing areas, a Toxicity Characteristic Leaching Procedure (TCLP) should be conducted to ensure that waste material does not exceed 5.0 ppm for lead and complies with the EPA waste disposal requirements for landfills.

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. FIGURES September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

FIGURES

BASEMENT

NO

TE

S;

LE

GE

ND ST

O

P

PO

SI

TI

VE

S

AM

PL

E

FO

R A

SB

ES

TO

S

N O

A

SB

ES

TO

S D

ET

EC

TE

D

(N

AD

SA

M

PL

E

PO

SI

TI

VE

F O

R A

SB

ES

TO

S

AP

PR

O

XI

M

AT

E

SA

M

PL

E

LO

C

AT

IO

N

8- A

8- A

8- A

8- A

0'

-0

AC

M S ur ve y Fl oo r P la n

- B as em en t

1.

AC

M F

LO

O

R T

IL

E

M

AS

TI

C

A

SS

U M

ED

E

XI

ST

IN

G

U N

D

ER

N

EW

FL

O O

R

IN

G S

TH

R

O U

G H

O U

T

BU

IL

D

IN

G

2.

AC

M P

IP

E

AN

D

F

IT

TI

N

G

IN

SU

LA

TI

O

N A

SS

U

M

ED

IN

W

AL

L

C H

AS

ES

AN

D

A

BO

VE

C

EI

LI

N G

S

TH

R O

U G

H O

U T

BU

IL

D

IN

G

3.

R

AD

IA

TO

R

H

EA

T

SH

IE

LD

S

AR

E

AC

M

4.

W

IN

D

O W

C

AU

LK

A

N D

G

LA

ZI

N

G A

R E

AC

M

AC

M

NO

TE

S;

8-

A

8-

A

8-

B

8-

B

8-

B

8-

A

8-

A

8-

A

8-

A

H

AT

C H

ED

A

R

EA

S

IN

D

IC

AT

E

PO

SI

TI

VE

D

ET

EC

TI

O N

O F

AS

BE

ST

O

S C

O N

TA

IN

IN

G

B U

IL

D

IN

G

C O

M

PO

N

EN

TS

"x

" F

LO

O

R T

IL

E

M

AS

TI

C

TE

S;

LE

GE

ND ST

O

P

PO

SI

TI

VE

S

AM

PL

E

FO

R A

SB

ES

TO

S

N O

A

SB

ES

TO

S D

ET

EC

TE

D

(N

AD

SA

M

PL

E

PO

SI

TI

VE

F O

R A

SB

ES

TO

S

AP

PR

O

XI

M

AT

E

SA

M

PL

E

LO

C

AT

IO

N

8- A

8- A

8- A

8- A

0'

-0

AC

M S ur ve y Fl oo r P la n

- F irs t F lo or

8-

B*

8-

A

8-

C

8-

A

8-

B

8-

A

8-

A

8-

A

8-

A*

8-

A

8-

B

8-

B

8-

A

8-

A

8-

B

8-

A

8-

B

8-

A

8-

A

8-

A

8-

A

8-

A

8-

A

8-

A

8-

A

8-

A

1.

AC

M F

LO

O

R T

IL

E

M

AS

TI

C

A

SS

U M

ED

E

XI

ST

IN

G

U N

D

ER

O

R

IN

G S

TH

R

O U

G H

O U

T

BU

IL

D

IN

G

2.

AC

M P

IP

E

AN

D

F

IT

TI

N

G

IN

SU

LA

TI

O

N A

SS

U

M

ED

IN

W

AL

L

C H

AS

ES

AN

D

A

BO

VE

C

EI

LI

N G

S

TH

R O

U G

H O

U T

BU

IL

D

IN

G

3.

R

AD

IA

TO

R

H

EA

T

SH

IE

LD

S

AR

E

AC

M

4.

W

IN

D

O W

C

AU

LK

A

N D

G

LA

ZI

N

G A

R E

AC

M

AC

M

NO

S;

S;

0'

-0

AC

M S ur ve y Fl oo r P la n

- S ec on d

Fl oo r

8-

A

8-

B

8-

B

8-

B

8-

B

8-

B

8-

A

8-

B

8-

B

8-

B

8-

B

8-

B

8-

D

8-

D

8-

B

8-

A

8-

B

LE

GE

ND ST

O

P

PO

SI

TI

VE

S

AM

PL

E

FO

R A

SB

ES

TO

S

N O

A

SB

ES

TO

S D

ET

EC

TE

D

(N

AD

SA

M

PL

E

PO

SI

TI

VE

F O

R A

SB

ES

TO

S

AP

PR

O

XI

M

AT

E

SA

M

PL

E

LO

C

AT

IO

N

8- A

8- A

8- A

8- A

8-

C

8-

C

1.

AC

M F

LO

O

R T

IL

E

M

AS

TI

C

A

SS

U M

ED

E

XI

ST

IN

G

U N

D

ER

O

R

IN

G S

TH

R

O U

G H

O U

T

BU

IL

D

IN

G

2.

AC

M P

IP

E

AN

D

F

IT

TI

N

G

IN

SU

LA

TI

O

N A

SS

U

M

ED

IN

W

AL

L

C H

AS

ES

AN

D

A

BO

VE

C

EI

LI

N G

S

TH

R O

U G

H O

U T

BU

IL

D

IN

G

3.

R

AD

IA

TO

R

H

EA

T

SH

IE

LD

S

AR

E

AC

M

4.

W

IN

D

O W

C

AU

LK

A

N D

G

LA

ZI

N

G A

R E

AC

M

AC

M

NO

S;

NO

TE

S;

LE

GE

ND ST

O

P

PO

SI

TI

VE

S

AM

PL

E

FO

R A

SB

ES

TO

S

N O

A

SB

ES

TO

S D

ET

EC

TE

D

(N

AD

SA

M

PL

E

PO

SI

TI

VE

F O

R A

SB

ES

TO

S

AP

PR

O

XI

M

AT

E

SA

M

PL

E

LO

C

AT

IO

N

8- A

8- A

8- A

8- A

0'

-0

AC

M S ur ve y Fl oo r P la n

- T hi rd F lo or

8-

C

8-

C

8-

B

8-

A

8-

A

8-

A

8-

B

8-

B*

8-

B

8-

B

8-

B*

8-

C

8-

B

8-

B

8-

A*

8-

C

8-

C

8-

C

8-

A

8-

A

8-

C

"x

" F

LO

O

R T

IL

E

M

AS

TI

C

H

AT

C H

ED

A

R

EA

S

IN

D

IC

AT

E

PO

SI

TI

VE

D

ET

EC

TI

O N

O F

AS

BE

ST

O

S C

O N

TA

IN

IN

G

B U

IL

D

IN

G

C O

M

PO

N

EN

TS

AC

M

B

LA

C K

SI

N

K C

O

AT

1.

AC

M F

LO

O

R T

IL

E

M

AS

TI

C

A

SS

U M

ED

E

XI

ST

IN

G

U N

D

ER

O

R

IN

G S

TH

R

O U

G H

O U

T

BU

IL

D

IN

G

2.

AC

M P

IP

E

AN

D

F

IT

TI

N

G

IN

SU

LA

TI

O

N A

SS

U

M

ED

IN

W

AL

L

C H

AS

ES

AN

D

A

BO

VE

C

EI

LI

N G

S

TH

R O

U G

H O

U T

BU

IL

D

IN

G

3.

R

AD

IA

TO

R

H

EA

T

SH

IE

LD

S

AR

E

AC

M

4.

W

IN

D

O W

C

AU

LK

A

N D

G

LA

ZI

N

G A

R E

AC

M

AC

M

NO

TE

S;

9" x9

" F

LO

O R

T

IL

E

9" x9

" F

LO

O R

T

IL

E M

AS

TI

C

FO

U

R

TH

F

LO

O R

U N

D

ER

C O

N

ST

R U

C

TI

O N

, N O

T

SU

R

VE

YE

D

NO

TE

S;

LE

GE

ND ST

O

P

PO

SI

TI

VE

S

AM

PL

E

FO

R A

SB

ES

TO

S

N O

A

SB

ES

TO

S D

ET

EC

TE

D

(N

AD

SA

M

PL

E

PO

SI

TI

VE

F O

R A

SB

ES

TO

S

AP

PR

O

XI

M

AT

E

SA

M

PL

E

LO

C

AT

IO

N

8- A

8- A

8- A

8- A

0'

-0

AC

M S ur ve y Fl oo r P la n

- F ou rth /F ift h

Fl oo r

8-

D

8-

A*

8-

A

8-

B

8-

B*

8-

B

8-

A

8-

B

AC

M

E

XT

ER

IO

R W

IN

D

O W

F R

AM

E

G

LA

ZI

N

G

H

AT

C H

ED

A

R

EA

S

IN

D

IC

AT

E

PO

SI

TI

VE

D

ET

EC

TI

O N

O F

AS

BE

ST

O

S C

O N

TA

IN

IN

G

B U

IL

D

IN

G

C O

M

PO

N

EN

TS

0'

-0

AC

M S ur ve y Fl oo r P la n

- F ift h Fl oo r

0'

-0

Le ad S ur ve y Fl oo r P la n

- B as em en t

LE

GE

ND

0'

-0

Le ad S ur ve y Fl oo r P la n

- F irs t F lo or

LE

0'

-0

Le ad S ur ve y Fl oo r P la n

- S ec on d

Fl oo r

LE

0'

-0

Le ad S ur ve y Fl oo r P la n

- T hi rd F lo or

LE

FO

U

R

TH

F

LO

O R

U N

D

ER

C O

N

ST

R U

C

TI

O N

, N O

T

SU

R

VE

YE

D

LE

GE

ND

0'

-0

Le ad S ur ve y Fl oo r P la n

- F ou rth F lo or

0'

-0

Le ad S ur ve y Fl oo r P la n

- F ift h Fl oo r

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. APPENDIX A September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

APPENDIX A

Accreditation Certificates

VOLUME II, BUILDING 138 - ASBESTOS & LEAD SURVEY REPORT

© 2020, Mabbett & Associates, Inc. Appendix A Page 1 of 1 September 25, 2020 Project No. R2019047.000.003 Appendix A - Certs

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. APPENDIX B September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

’S TEMPLATE

APPENDIX B

Table 3 - Summary of ACM Sampling Results

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. APPENDIX B September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

TABLE 3

VA Northern Indiana Health Care System

Marion VAMC, Building 138 Summary of ACM Sampling Results

Sample No. Sample Location Description of Material Percent and Type of Asbestos 138-01A Room S103 Wall Plaster (Base Coat) NAD 138-01B Room 278 Wall Plaster (Base Coat) NAD 138-01C Room 317B Wall Plaster (Base Coat) NAD 138-02A Room S103 Wall Plaster (Skim Coat) NAD 138-02B Room 278 Wall Plaster (Skim Coat) NAD 138-02C Room 317B Wall Plaster (Skim Coat) NAD 138-03A Room 160A Gypsum Wallboard NAD 138-03B Room 230 Gypsum Wallboard NAD 138-03C Room 348 Gypsum Wallboard NAD 138-04A Room 160A Joint Compound NAD 138-04B Room 230 Joint Compound NAD 138-04C Room 348 Joint Compound NAD 138-05A Ambulance Garage Spray On Insulation NAD 138-05B Ambulance Garage Spray On Insulation NAD 138-05C Ambulance Garage Spray On Insulation NAD 138-06A Room 136 2'x2' White Fissure Ceiling Tile NAD 138-06B Room 278 2'x2' White Fissure Ceiling Tile NAD 138-06C Room 333A 2'x2' White Fissure Ceiling Tile NAD 138-07A Corridor at Room 103 2'x2' White Ceiling Tile NAD 138-07B Corridor at C100 2'x2' White Ceiling Tile NAD

138-08A Room 253 2'x2' White Ceiling Tile (Gypsum Wallboard) NAD

138-08B Room 253 2'x2' White Ceiling Tile (Gypsum Wallboard) NAD

138-09A 3rd Floor South End Hall 2'x4' Fissure Ceiling Tile NAD 138-09B 2nd Floor Corridor Outside Room 301 2'x4' Fissure Ceiling Tile NAD 138-10A Room 160A 4" Cove Base NAD 138-10B Room 230 4" Cove Base NAD 138-11A Room 160A 4" Cove Base Adhesive NAD 138-11B Room 230 4" Cove Base Adhesive NAD 138-12A Room 003 6" Cove Base NAD 138-12B Room 304 6" Cove Base NAD 138-13A Room 003 6" Cove Base Adhesive NAD 138-13B Room 304 6" Cove Base Adhesive NAD 138-14A 1st Floor Corridor at Room 103 Red Fire Stop NAD 138-14B Room 238 Red Fire Stop NAD

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. APPENDIX B September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

TABLE 3

VA Northern Indiana Health Care System

Marion VAMC, Building 138 Summary of ACM Sampling Results

Sample No. Sample Location Description of Material Percent and Type of Asbestos 138-14C Room 315 Red Fire Stop NAD 138-14D 5th Floor South Red Fire Stop NAD 138-15A Room 114 Black Sink Coat NAD 138-15B Room 372C Black Sink Coat 3% Chrysotile 138-16A Room 203 Gray Sink Coat NAD 138-16B Room 224 Gray Sink Coat NAD 138-17A Across From Room 106 Black Damp Proofing NAD 138-17B Room 278 Black Damp Proofing NAD 138-17C Room 301 Black Damp Proofing NAD 138-18A Room 226 Carpet Adhesive NAD 138-18B Room 351 Carpet Adhesive NAD 138-19A Room 307 Heater Panel (Cement Board) 20% Chrysotile 138-20A Room 013 Corkboard Ceiling Panels NAD 138-20B Room 013 Corkboard Ceiling Panels NAD 138-21A Room 013 White Fiberglass End Sealant NAD 138-21B Room 013 White Fiberglass End Sealant NAD 138-22A Room 013 Grey Duct Sealant NAD 138-22B Room 013 Grey Duct Sealant NAD

138-23A Room 010 12"x12" White and Gray Mottled Floor Tile NAD

138-23B Corridor Outside Room 017 12"x12" White and Gray Mottled Floor Tile NAD

138-23C Room 265 12"x12" White and Gray Mottled Floor Tile NAD

138-23D Outside Room 232 12"x12" White and Gray Mottled Floor Tile NAD

138-24A Room 010 12"x12" White and Gray Mottled Floor Tile Mastic NAD

138-24B Corridor Outside Room 017 12"x12" White and Gray Mottled Floor Tile Mastic NAD

138-24C Room 265 12"x12" White and Gray Mottled Floor Tile Mastic NAD

138-24D Outside Room 232 12"x12" White and Gray Mottled Floor Tile Mastic NAD

138-25A Outside Room 301 12"x12" Tan Floor Tile NAD 138-25B Outside Room 367A 12"x12" Tan Floor Tile NAD

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. APPENDIX B September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

TABLE 3

VA Northern Indiana Health Care System

Marion VAMC, Building 138 Summary of ACM Sampling Results

Sample No. Sample Location Description of Material Percent and Type of Asbestos 138-26A Outside Room 301 12"x12" Tan Floor Tile Mastic NAD 138-26B Outside Room 367A 12"x12" Tan Floor Tile Mastic NAD 138-27A Outside Room 347 12"x12" Beige Floor Tile NAD 138-27B Outside Room 367 12"x12" Beige Floor Tile NAD 138-28A Outside Room 347 12"x12" Beige Floor Tile Mastic NAD 138-28B Outside Room 367 12"x12" Beige Floor Tile Mastic 3% Chrysotile 138-29A Room 160A 12"x12" Gray and Blue Floor Tile NAD

138-30A Room 160A 12"x12" Gray and Blue Floor Tile Mastic NAD

138-31A Room 153 12"x12" Teal Floor Tile NAD 138-32A Room 153 12"x12" Teal Floor Tile Mastic NAD 138-33A S6 12"x12 Pink Floor Tile NAD 138-33B Elevator S5 12"x12 Pink Floor Tile NAD 138-34A S6 12"x12 Pink Floor Tile Mastic NAD 138-34B Elevator S5 12"x12 Pink Floor Tile Mastic NAD 138-35A Exterior 5th Floor East Exterior Window Frame Glaze 3% Chrysotile 138-35B Exterior 5th Floor East Exterior Window Frame Glaze NA/PS 138-36A Exterior 5th Floor East Exterior Window Frame Caulk NAD 138-36B Exterior 5th Floor East Exterior Window Frame Caulk NAD

138-37A - A Exterior Northeast Area of Building Gray Window Frame Caulk 2% Chrysotile

138-37A - B Exterior Northeast Area of Building Gray Window Frame Caulk NA/PS

138-37B - A Exterior Southeast Area of Building Gray Window Frame Caulk NAD

138-37B - B Exterior Southeast Area of Building Gray Window Frame Caulk NAD

138-38A Exterior East Main Entrance (North) Exterior Brown Door Frame Caulk NAD 138-38B Exterior East Main Entrance (North) Exterior Brown Door Frame Caulk NAD

Notes:

NAD = No Asbestos Detected NA/PS = Not Analyzed / Positive Stop

A’S TEMPLATE

© 2020, Mabbett & Associates, Inc. APPENDIX C September 25, 2020 Project No. R2019047.000.003 VANIHCS_Marion VAMC Volume II Bldg. 138 ACM LBP Survey Report V1 - Final

APPENDIX C

Laboratory Analytical Results and Chain of Custody

Bulk Asbestos Analysis By Polarized Light Microscopy

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 1A all laster Base Coat ray on ibrous eterogeneous

Crus ed71937617PLM_1 ther 100 one Detected138 1B all laster Base Coat ray on ibrous eterogeneous

Crus ed71937617PLM_2 ther 100 one Detected138 1C all laster Base Coat ray on ibrous eterogeneous

Crus ed71937617PLM_3 ther 100 one Detected138 A all laster Ski Coat ite on ibrous eterogeneous

Crus ed71937617PLM_4 ther 100 one Detected138 B all laster Ski Coat ite on ibrous eterogeneous

Crus ed71937617PLM_5 ther 100 one Detected138 C all laster Ski Coat ite on ibrous eterogeneous

Crus ed71937617PLM_6 ther 100 one Detected138 3A y su allboard Bro n ite ibrous eterogeneous eased71937617PLM_7

Cellulose ypsum 40 60 one Detected138 3B y su allboard Bro n ite ibrous eterogeneous eased71937617PLM_8

Cellulose ypsum 40 60

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

S aron onald 8 r1 1 1 1

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 3C y su allboard Bro n ite ibrous eterogeneous eased71937617PLM_9

Cellulose ypsum 40 60 one Detected138 A oint Co ound ite on ibrous o ogeneous

Crus ed71937617PLM_10 ther 100 one Detected138 B oint Co ound ite on ibrous o ogeneous

Crus ed71937617PLM_11 ther 100 one Detected138 C oint Co ound ite on ibrous o ogeneous

Crus ed71937617PLM_12 ther 100 one Detected138 A S ray n nsulation ray ibrous o ogeneous eased71937617PLM_13

Cellulose ther ermiculite 30 6 one Detected138 B S ray n nsulation ray ibrous o ogeneous eased71937617PLM_14 one Detected138 C S ray n nsulation ray ibrous o ogeneous eased71937617PLM_15 one Detected138 A ite issure Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_16

Cellulose Mineral ool

Perlite ther

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 B ite issure Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_17

Cellulose Mineral ool

Perlite ther one Detected138 C ite issure Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_18

Cellulose Mineral ool

Perlite ther one Detected138 A ite Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_19

Cellulose Mineral ool

Perlite ther one Detected138 B ite Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_20

Cellulose Mineral ool

Perlite ther one Detected138 8A ite Ceiling ile y su allboard ite ibrous eterogeneous eased71937617PLM_21

Cellulose Fiber lass ypsum 0 one Detected138 8B ite Ceiling ile y su allboard Bro n ite ibrous eterogeneous eased71937617PLM_22

Cellulose Fiber lass ypsum ther one Detected138 A issure Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_23

Cellulose Mineral ool

Perlite ther one Detected138 B issure Ceiling ile ray ite ibrous eterogeneous eased71937617PLM_24

Cellulose Mineral ool

Perlite ther

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 1 A Cove Base ray on ibrous o ogeneous

As ed71937617PLM_25 ther 100 one Detected138 1 B Cove Base ray on ibrous o ogeneous

As ed71937617PLM_26 ther 100 one Detected138 11A Cove Base Ad esive ite on ibrous o ogeneous issolved71937617PLM_27 ther 100 one Detected138 11B Cove Base Ad esive ite on ibrous o ogeneous issolved71937617PLM_28 ther 100 one Detected138 1 A Cove Base Bro n on ibrous o ogeneous

As ed71937617PLM_29 ther 100 one Detected138 1 B Cove Base Bro n on ibrous o ogeneous

As ed71937617PLM_30 ther 100 one Detected138 13A Cove Base Ad esive mixed adhesives ite ello on ibrous eterogeneous issolved71937617PLM_31 ther 100 one Detected138 13B Cove Base Ad esive mixed adhesives ite ello on ibrous eterogeneous issolved71937617PLM_32 ther 100

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 1 A ed ire Sto ed on ibrous o ogeneous

As ed71937617PLM_33

Fiber lass ther 3 97 one Detected138 1 B ed ire Sto ed on ibrous o ogeneous

As ed71937617PLM_34

Fiber lass ther 3 97 one Detected138 1 C ed ire Sto ed on ibrous o ogeneous

As ed71937617PLM_35

Fiber lass ther 3 97 one Detected138 1 ed ire Sto ed on ibrous o ogeneous

As ed71937617PLM_36

Fiber lass ther 3 97 one Detected138 1 A Bla k Sink Coat Bla k on ibrous o ogeneous issolved71937617PLM_37 ther 100

3 Chrysotile138 1 B Bla k Sink Coat Bro n Bla k on ibrous eterogeneous issolved71937617PLM_38 ther 97 one Detected138 1 A ray Sink Coat ray on ibrous o ogeneous issolved71937617PLM_39

Cellulose ther 1 one Detected138 1 B ray Sink Coat ray on ibrous o ogeneous issolved71937617PLM_40

Cellulose ther 1

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 1 A Bla k a roo ing ray Bla k on ibrous eterogeneous issolved71937617PLM_41 ther 100 one Detected138 1 B Bla k a roo ing ray Bla k on ibrous eterogeneous

Crus ed issolved71937617PLM_42 ther 100 one Detected138 1 C Bla k a roo ing ray Bla k on ibrous eterogeneous

Crus ed issolved71937617PLM_43 ther 100 one Detected138 18A Car et Ad esive ello on ibrous o ogeneous issolved71937617PLM_44 ther 100 one Detected138 18B Car et Ad esive ello on ibrous o ogeneous issolved71937617PLM_45 ther 100

0 Chrysotile138 1 A eater anel Ce ent Board ray ibrous eterogeneous eased71937617PLM_46 ther 0 one Detected138 A Corkboard Ceiling anels Bro n on ibrous o ogeneous issolved71937617PLM_47 ther 100 one Detected138 B Corkboard Ceiling anels Bro n on ibrous o ogeneous issolved71937617PLM_48 ther 100

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 1A ite iberglass nd Sealant ite on ibrous o ogeneous issolved71937617PLM_81

Cellulose ther 10 90 one Detected138 1B ite iberglass nd Sealant ite on ibrous o ogeneous issolved71937617PLM_82

Cellulose ther 10 90 one Detected138 A rey u t Sealant ray on ibrous o ogeneous issolved71937617PLM_83 ther 100 one Detected138 B rey u t Sealant ray on ibrous o ogeneous issolved71937617PLM_84 ther 100 one Detected138 3A 1 1 ite and ray Mottled loor ile ray ite on ibrous o ogeneous issolved71937617PLM_49 ther 100 one Detected138 3B 1 1 ite and ray Mottled loor ile ray ite on ibrous o ogeneous issolved71937617PLM_50 ther 100 one Detected138 3C 1 1 ite and ray Mottled loor ile ray ite on ibrous o ogeneous issolved71937617PLM_51 ther 100 one Detected138 3 1 1 ite and ray Mottled loor ile ray ite on ibrous o ogeneous issolved71937617PLM_52 ther 100

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 A 1 1 ite and ray Mottled loor ile Masti ello on ibrous o ogeneous issolved71937617PLM_53 ther 100 one Detected138 B 1 1 ite and ray Mottled loor ile Masti ello on ibrous o ogeneous issolved71937617PLM_54 ther 100 one Detected138 C 1 1 ite and ray Mottled loor ile Masti ello on ibrous o ogeneous issolved71937617PLM_55 ther 100 one Detected138 1 1 ite and ray Mottled loor ile Masti ello on ibrous o ogeneous issolved71937617PLM_56 ther 100 one Detected138 A 1 1 an loor ile an on ibrous o ogeneous issolved71937617PLM_57 ther 100 one Detected138 B 1 1 an loor ile an on ibrous o ogeneous issolved71937617PLM_58 ther 100 one Detected138 A 1 1 an loor ile Masti yellow mastic ello on ibrous o ogeneous issolved71937617PLM_59 ther 100 one Detected138 B 1 1 an loor ile Masti black mastic - small sample

Bla k on ibrous o ogeneous issolved71937617PLM_60

Cellulose ther 3 97

Disclaimer: Due to the nature o the EPA 600 method, asbestos may not be detected in samples containing lo le els o asbestos. e strongly recommend that analysis o loor tiles, ermiculite, and/or heterogeneous soil samples be conducted by EM or con irmation o one Detected by PLM. his report relates only to the samples tested and may not be reproduced, e cept in ull, ithout the ritten appro al o SAI. his report may not be used by the client to claim product endorsement by LAP or any other agency o the .S. go ernment. Analytical uncertainty a ailable upon re uest. Scienti ic Analytical Institute participates in the LAP Pro iciency esting program. nless other ise noted blan sample correction as not per ormed. Estimated MDL is 0.1 .

Appro ed SignatoryAnalyst Scienti ic Analytical Institute, Inc. 4604 Dundas Dr. reensboro, C 7407 336 9 -3

EPA Method: 600/R-93/116 and 40 CFR, Part 763, Subpart E, App.E

Marion VAMC Asbestos SurveyBuilding 138Project:

Sample ID Lab Sample ID

Description Lab Notes Asbestos Fibrous

Components on-Fibrous

Components Attributes reatment

Mi ael elaney Brendan Clune

Attn:Customer: Mabbett Asso iates n 1 Central Street Suite 1 Stone a MA 18

Analysis ID: 1 3 1 M

Date Reported: 3 Date Recei ed: 3

Lab rder ID: 1 3 1 one Detected138 A 1 1 Beige loor ile Beige on ibrous o ogeneous issolved71937617PLM_61 ther 100 one Detected138 B 1 1 Beige loor ile Beige on ibrous o ogeneous issolved71937617PLM_62 ther 100 one Detected138 8A 1 1 Beige…